Ldb1 is an essential co-regulator of transcription in embryonic development. It acts in conjunction with nuclear LIM-homeodomain and LIM-only proteins to control key events of organogenesis as precursor cells enter lineage specification. Here we ask whether Ldb1 exerts control over stem cell activation and differentiation throughout the life of the organism as required for tissue homeostasis. To help answer this question, we have generated conditional Ldb1 mouse mutants with an Ldb1 floxed/floxed;ROSA26CreER genotype. Tamoxifen treatment of 60 day-old mutant animals results in near-ubiquitous Cre-mediated Ldb1 inactivation. As a consequence, the stem cell microenvironment of intestinal crypts is drastically affected. Cells that normally express Ldb1 together with markers that identify them as lineage progenitors cease to retain bromodeoxyuridine and are gradually lost. Ldb1 inactivation in intestinal crypts and/or in neighboring mesenchymal cells also triggers activation of Wnt signaling in the stem cell niches of the small intestine. Cell proliferation is markedly increased in the epithelia of the small intestine, and Lgr5-expressing stem cells disappear from the base of the crypts. This perturbation of the normal process of tissue homeostasis causes apoptosis, and the animals do not survive. We conclude that Ldb1-mediated transcriptional regulation plays a major role in adult intestinal homeostasis.
Introduction
Tissue homeostasis is maintained through periodical replacement of cells. This process originates from special micro environments or niches that contain stem cells able to self-renew or to differentiate into multiple cell lineages. Each tissue has its own replacement cycle. Thus, intestinal epithelia of the mouse completely self-renew approximately every five days 1 , while the interfollicular epidermis and corneal epithelium are replaced in a span of several weeks 2 . Balanced canonical Wnt/β-catenin signaling is essential for the maintenance of a stem cell pool able to self renew and to give rise to lineage precursors. Mutations that affect components of this Wnt pathway can result in hyperproliferation of the epithelia [3] [4] [5] [6] , while overexpression of the Wnt inhibitor Dkk1 can cause complete loss of proliferation [7] [8] [9] . Finally, lack of the Wnt inhibitor Dkk2 can alter the fate of corneal stem cells 10 .
The gut tube of the small intestine is characterized by protrusions towards the lumen, called villi, and by crypts or invaginations into the submucosa. Genetic fate mapping has established that the niche containing multipotent stem cells of the small intestine is located at or near the base of the crypts 11, 12 . The canonical Wnt signaling pathway is a known regulator of cell proliferation during development and maintenance of the intestinal epithelium. Wnt-activated cells express putative stem cell markers like Musashi-1, but not most cell differentiation markers 13 . Consistent with this, conditional treatment of adult mice with Dkk1 encoded by adenovirus vectors leads to a precipitous down regulation of the Wnt target genes CD44 and EphB2 in the small intestine and colon. Cell proliferation in these tissues is inhibited, followed by loss of crypts and villi. Several days later, severe defects in glandular structure are observed, leading to substantial mortality from colitis and systemic infection 8 . The same study showed that decreased reduction of Dkk1 expression at later time points (>10 days) resulted in crypt and villus regeneration. Conversely, ectopic expression of the Wnt inhibitor Dkk1 in the small intestine leads to blockage of the Wnt signaling pathway thus affecting proliferation and differentiation of the epithelial cells in the crypts 9 . Finally, Wnt signaling in self-renewing tissues such as the intestine is tightly regulated as expression of Wnt ligands, downstream effector genes, Wnt receptors and co-receptors, as well as Wnt-pathway inhibitors has been well documented in both the epithelial and mesenchymal tissues of the small intestine 14 . Thus it is likely that cross talk between epithelial and mesenchymal cells play a central role in epithelial tissue homeostasis in the small intestine. The need for balanced canonical Wnt signaling has been demonstrated in studies showing that proliferative cells at the bottom of the crypts accumulate nuclear β-catenin 15 and activation of Wnt/ β-catenin signaling in mutants leads to adenomatous polyp formation in the mouse intestine 16, 17 . Ldb1 binds to the LIM motif of nuclear LIM-homeodomain proteins and acts as their transcriptional co-regulator at multiple stages of embryonic development 18, 19 . Ldb1 null mutant mice are characterized by early and profound defects in brain and heart formation and severe impairment of mesoderm-derived extraembryonic structures 20 . Comparable effects of Ldb1 and Dkk2 loss-of-function have been observed in mutant mice showing that both genes are tied in with programs of epithelial fate determination 10, 21 . Thus, a connection has been established between Ldb1 function and canonical Wnt pathway regulation in epithelia. In the skin the LIM-homeodomain product of the Lhx2 gene, a likely partner of Ldb1-mediated action, is required as the stem cell progeny give rise to the various epidermal cell lineages 22 . Together, these observations indicate that Ldb1 proteins play an important role in adult tissue homeostasis. Our initial finding that Ldb1 is also readily expressed in the epithelial cells of the villi and the crypts as well as the mesenchyme of the small intestine (E. Makarev, personal communication) strongly suggests that Ldb1 plays a role in tissue renewal of the gut epithelia as well.
Here we report on the function of the Ldb1 gene in epithelial tissue homeostasis of adult mice. In the small intestine Ldb1 is prominently expressed in the epithelial cells of the villi, the crypts and in the mesenchyme. Conditional ablation of Ldb1 function results in a devastating effect on intestinal tissue turnover caused by a loss of slow cycling stem cells from the crypts of the small intestine. These observations reveal a critical role of Ldb1 in the regulation of adult tissue homeostasis.
Results and Discussion

Ldb1 is expressed in the stem cell niche compartments of the small intestines of adult mice
Adult mice, two months of age, were utilized throughout this study. We examined Ldb1 expression in the small intestines of control mice with anti-Ldb1 antibody, which specifically labels nuclei 23, 24 . The morphology and location of Ldb1-positive cells allow us to conclude that Ldb1 is expressed in the epithelial cells of the villi and the crypts including the Paneth cells and undifferentiated Transiently Amplifying (TA) cells (Fig. 1A) . Scattered Ldb1-expression was also detected in the adjacent mesenchymal tissue (Fig.  1B) .
Cells expressing the Wnt target gene Lgr5 (Leucine-rich-repeat-containing G-protein-coupled Receptor 5, also known as Gpr49) are located at the base of the crypts (Fig. 1C) . Lineage tracing has identified these cells as stem cells 11 . A comparison of Figs. 1B and 1C allows us to conclude that the cells expressing Lgr5 transcripts also strongly stain for Ldb1.
Conditional inactivation of Ldb1 results in loss of stem cells from the niche compartments of the small intestine
We used a loss-of-function approach to study the functional role of Ldb1 in the adult mouse. Our earlier studies established that zygotic ablation of Ldb1 results in early embryonic lethality 20 . For this reason, we resorted to Cre-mediated inactivation of a floxed Ldb1 allele previously generated in our laboratory 25 .
The R26CreER mouse can be induced by tamoxifen to express Cre under the control of the ROSA26 promoter in a wide variety of tissues 26 . The effect of tamoxifen treatment on Ldb1 expression is quite dramatic in the intestines of conditionally mutant (Ldb1 fl/fl ;R26CreER) compared to control mice ( Fig.  2A-C) . We refer to both Ldb1 fl/+ ;R26CreER and Ldb1 fl/fl genotypes as controls because these mice are indis-tinguishable from wild type or from R26CreER mice in the experiments described below. For a study of the short-term effects of the tamoxifen-induced Ldb1 deletion, mice were sacrificed 24 hrs after tamoxifen treatment (short-term mutants). A second group of mice were sacrificed 7 days after tamoxifen treatment to study the long-term effect of Ldb1 deletion (long-term mutants). The effect of Ldb1 deletion could not be observed at later time points because mutant mice did not survive more than 7 days after treatment. In control intestines over 83% of nuclei in the crypts and the adjacent mesenchyme stain prominently with the anti-Ldb1 antibody ( Fig. 2A, C) . In contrast, in short-term Ldb1 fl/fl ;R26CreER mutant intestines, the number of Ldb1-positive cells in the crypts is sharply reduced to 36% (Fig. 2B, C) . Therefore, tamoxifen-mediated induction of Cre results in an average 2.3-fold reduction of Ldb1-labeled cells detected in the crypts (Fig. 2C) . Quantification of this data is described in experimental procedures and in Figure 2C .
In order to determine the effect of the Ldb1 deletion on stem cells we compared Lgr5 expression in floxed Ldb1 mutant crypts with that of controls. Cells in the niche compartment near the base of the crypts of control mice are clearly marked by Lgr5 in situ hybridization (Fig. 2D) . A similar level of Lgr5 signal was seen in the short-term mutant (Fig. 2E) . However, after long-term deletion of the Ldb1 gene this signal was markedly reduced and appeared non-specific (Fig. 2F) . We conclude that the conditional inactivation of Ldb1 in adult mouse tissues results in a loss of the stem cells from niche compartments in the small intestine.
Ldb1 controls cell proliferation in the crypts of the small intestine
The prominent expression of Ldb1 in the crypts of the small intestine seen in Fig. 1A , as well as the loss of Lgr5 in the stem cells following Ldb1 deletion, suggested the possibility that Ldb1 plays a role in the regulation of cell proliferation in the stem cell niche of this tissue. We therefore asked whether ablation of Ldb1 would affect the rate of incorporation of the synthetic thymidine analog bromodeoxyuridine (BrdU) into the DNA of replicating intestinal cells. We administered BrdU by intraperitoneal (IP) injection each day for two days along with tamoxifen, and BrdU alone once more on the third day. A group of "short-chase" mice was sacrificed 5 hrs thereafter, while a second "long chase" group was sacrificed after 7 days.
Previous studies have shown that multipotent stem cells of the small intestine are slow cycling but can give rise to rapidly proliferating daughter cells, referred to as TA or Transiently Amplifying cells, which fill the crypts with committed lineage precursor cells (reviewed in 4 ). In our experiments, a short chase timeframe was sufficient to show that the number of cells staining for anti-Phospho Histone H3 (PH3), a marker for cells in active mitosis, is increased in the mutant crypts, indicating unusually high proliferation (compare Figs. 3A, B) . At the same time, the level of BrdU incorporation not only increases in mutant crypt cells (Fig. 3D) but is now also observed in the villi cells, which in control animals do not incorporate BrdU, as they are mainly composed of terminally differentiated, nonproliferating columnar epithelial cells (compare Figs. 3C, D) . BrdU-positive cells are also found in the stem cell niches of mutant crypts at a much higher rate than in control crypts (Fig. 3C, D, arrows) . These results suggest the slow cycling stem cells of control crypts are proliferating more rapidly in the absence of Ldb1. short chase, BrdU pulse of 3 days followed by sacrifice of mice after four hours; long chase, BrdU pulse of 3 days followed by sacrifice of mice after 7 days; PH3, Phospho HistoneH3 antibody and BrdU, bromodeoxyuridine.
In contrast to the short chase results, after a long chase about 85% of the mutant crypts no longer retain any BrdU signal (Fig. 3F, G) while the label persists in about 50% of the control crypts (Figs. 3E, G) . Taken together, these results suggest that the unusual BrdU-labeled cells in the short chase mutant villi are derived from cells of hyperproliferating crypts that have migrated away from the BrdU-label retaining stem cell niche 13 . We further observe that the initial upregulation of cell division seen in the crypts of the short chase mutants (Fig. 3D) leads to an increase in number of cells populating the mutant crypts after a period of 7days (Fig. 3F) . These findings are consistent with the idea that Ldb1 maintains a slow cycling stem cell pool in the crypts that is compromised when the gene is inactivated.
Ldb1 is known to mediate the activity of transcription factors encoded by the Lhx genes, and Lhx2 is known to play a vital role in hair stem cell maintenance in the bulge 22 . Our findings thus underscore the importance of Ldb1 and associated factors in the transcriptional control of this process.
The morphology of the small intestine is altered upon prolonged Ldb1 ablation
We were interested to know how deletion of Ldb1 affects gut morphology over time. To this end, we treated Ldb1 fl/fl ;R26CreER mutants and control mice with tamoxifen for two days and sacrificed the animals one week later. Whereas the small intestines of the controls appear morphologically unremarkable (Fig. 4A) , the same tissue in the Ldb1 deleted mice appears grossly abnormal (Fig. 4B) . Collapse of the mutant small intestine was confirmed through TUNEL staining. Apoptosis was evident in the mutant, but not in control crypts (Figs. 4C and D) . 
Ldb1 ablation leads to activation of the Wnt/β-catenin pathway in the intestinal crypts
Stem cell division is preceded by activation of the Wnt/β-catenin pathway during epithelial tissue regeneration 27 . Therefore we examined β-catenin activity in the crypts of the conditionally-deleted Ldb1 mutant mice through immunostaining using anti-β-catenin antibody. Consistent with the published literature 13 , we observe that in our control mice the Wnt/β-catenin staining is excluded from the nuclei in the crypt cells (Fig. 5A, B) . However in the conditionally deleted Ldb1 mutant, abnormal activation of this pathway manifests as nuclear β-catenin immunostaining in almost all the crypt cells (Fig.  5C,D) . We conclude that loss of Ldb1 from the small intestine leads to activation of the Wnt/ β-catenin signaling pathway. This is consistent with a previous observation that the Ldb1 gene positively regulates the expression of several Wnt pathway inhibitors 20 .
Our study addresses the function of the transcriptional co-regulator Ldb1 in the small intestine. Ldb1 is prominently expressed in the epithelia of this organ. Tamoxifen-induced activation of Cre acts on floxed Ldb1 alleles and causes their inactivation. The resulting loss of Ldb1 function profoundly affects the stem cell microenvironment of intestinal crypts. Cells in the stem cell niches of these crypts that normally express Ldb1, together with markers that identify them as lineage progenitors, are gradually lost and cease to incorporate BrdU. The small intestine, well known for its rapid turnover of epithelia, is severely affected by this disturbance of the niche environment. We observed a sharp increase of cell proliferation in the gut epithelia and a concomitant loss of slow cycling, Lgr5-expressing stem cells from the base of the crypts.
This perturbation of the normal process of tissue homeostasis is not compatible with cell and tissue viability, hence the eventual onset of apoptosis which the animals did not survive. Additionally, Ldb1 inactivation triggers the canonical Wnt/ß-catenin pathway. We observed a marked increase of anti-ß-catenin immunostaining in the nuclei of the mutant crypt cells including the cells of the niche.
Wnt/ß-catenin signaling plays an indispensable role in the regulation of epithelial stem cells. These signals are involved in the control of stem cell quiescence and activation as well as cell migration and differentiation 2 . We show that Ldb1 affects the output of these signals in the small intestine. This suggests a mechanism whereby Ldb1 interacts with other transcriptional regulators to control gene products that influence Wnt output levels. Ldb1 is known to positively influence the expression of several Wnt inhibitors 10 while Lgr5 is a negative regulator of the Wnt pathway 28 . It is possible that Wnt inhibitors encoded by Dkk genes are among the target genes for Ldb1-mediated transcriptional control since these genes are known to play crucial roles in epithelial tissue homeostasis. For example, it is known that overexpression of Dkk1 results in a failure to develop hair follicles 1 , reduces epithelial proliferation and causes a loss of intestinal crypts 9 . Likewise, the related Dkk2 gene is a key regulator of corneal versus epidermal fate of the ocular surface epithelium 10 . Ldb1 knockdown sets off a precipitous wave of proliferation and exit of cells from the niche compartments of the small intestine. Interestingly, previous reports have shown that increased Wnt-signaling is correlated with increased proliferation in the crypts of the small intestine 13 . In our BrdU pulse-labeled experiments we noted that Ldb1 inactivation causes a substantial increase of BrdU incorporation in epithelial cells extending beyond the crypts and into the villi of the small intestine. The fact that Lgr5-expressing crypt cells are concomitantly lost strongly suggests that at least a portion of the BrdU-positive cells in the villi are descendants of untimely activated niche stem cells.
We find Ldb1 broadly expressed in the small intestine, in the villi and crypt epithelia as well as in the adjacent mesenchyme. Interaction between these two tissue layers and the involvement of transcription factors in this process has long been recognized as an important determinant of cell fate 29 . It has been established that such tissue interactions play a central role in tissue homeostasis in the skin and the cornea 10, 27 . In our experimental setting, all ROSA26CreER-expressing cells are subject to tamoxifen-induced Ldb1 inactivation, including both epithelial and mesenchymal cells. In order to determine if both or one of these tissues are critical for Ldb1-mediated transcriptional control of niche activity, selective conditional Ldb1 inactivation in individual compartments will be required. A recent study showed that incomplete inactivation of the Ascl2 gene activity in epithelial cells of the small intestine leads to a partial loss of stem cells in intestinal crypts, followed by a recovery of the stem cell niche through crypt fission, a repair mechanism believed to be activated after injury or genetic damage 30 . In contrast, results of our study demonstrate that a 2.3-fold reduction of Ldb1 expression in both epithelial and mesenchymal tissues is sufficient for complete collapse of the small intestinal structure, suggesting that mesenchymal tissue might play a crucial role in the tissue repair process. Current experiments aim at testing the effect of gut mesenchyme-specific Ldb1 ablation by developing a Cre allele that can be conditionally expressed in this tissue.
In conclusion, we show that Ldb1 plays a key regulatory role in transcriptional events that govern the biological process of epithelial tissue homeostasis in mammalian small intestine. The mechanism of this process, as well as its broader implications for homeostasis elsewhere in the adult organism, remain to be elucidated.
Experimental procedures
Mice
The Ldb1 conditional mutant allele was generated in our laboratory by inserting two LoxP sites, one upstream of the protein coding region and the other into the ninth intron of the Ldb1 gene 25 . This conditional Ldb1 fl/fl mutant was mated with Rosa26CreER mice (Jackson Laboratory #004847) to generate Ldb1 fl/fl ;Rosa26CreER offspring that can be subjected to tamoxifen-mediated Ldb1 inactivation.
Tamoxifen induction and BrdU injection
Eight week-old mice were given 0.5ml of a 20 mg/ml dilution of tamoxifen (Sigma) in corn oil (Sigma) by oral gavage once a day for two days. Mice were injected intraperitoneally once a day for three days with 0.2ml of BrdU (Sigma) solution in PBS at 10mg/ml. Mice were sacrificed four hours ("short chase") or seven days ("long chase") after BrdU injection. Ldb1 deletion was calculated on an average of 1000 cells from 300 crypts per mouse with three mice each for control and mutant. In the controls, 21-32 cells per crypt immunostained for Ldb1 (an average of 25 ± 3.8 out of 30 total cells per crypt) while in the mutants it was 5-15 cells per crypt (averaging 9 ± 4.1 out of 25 total cells per crypt). In a 4µm section, the deletion varied from 40% in 300 crypts, 60% in 200 crypts, 70% in 300 crypts and 90% in 100 crypts.
Histology
The gut was dissected and fixed in 4% Paraformaldehyde (PFA) in PBS. Samples were then embedded in paraffin blocks, and sectioned at 4μm and 6μm, respectively. For histological analysis, sections were stained with hematoxylin and eosin (H&E) (Sigma).
Immunohistochemistry
Brightfield: Sections were deparaffinized, rehydrated and washed in 1 X PBS. Endogenous peroxidase activity was quenched with 3% hydrogen peroxide in methanol for 30 min. Heat Induced Epitope Retrieval (HIER) was performed on mouse small intestine sections in Buffer A for 20min utilizing a pressurized de-cloaking chamber (Prestige Medical). The sections were washed and incubated in blocking serum (3%; Vector Laboratories) at room temperature for 60min to block non-specific binding. Thereafter the sections were exposed to primary antibodies, rabbit anti-Ldb1 (kindly provided by Drs. L.-Q. Li and P. Love, NICHD, NIH), and rabbit anti-PhosphoHistone H3 (Ser10, Upstate), overnight at 4 o C. After primary antibody incubation, sections were washed in PBS, incubated with biotinylated secondary antibodies (Vector Laboratories) and processed with a Vectastain ABC kit (Vector Laboratories). The sections were developed by using AEC as chromogen (Zymed), counterstained with Hematoxylin, and mounted with Aqua PolyMount (Polysciences).
Fluorescence: Sections were deparaffinized, rehydrated and washed in 1 X PBS. HIER was performed and sections were incubated in goat or fetal calf blocking serum (3%) (Vector Laboratories) followed by incubation in primary antibodies, rabbit anti-Ldb1, rabbit anti-Phospho-Histone H3 (Ser10), mitosis marker (Upstate), goat β-catenin (Cell Signaling), overnight at 4 o C. Sections were sequentially exposed to appropriate fluorescein-tagged Alexa Fluor secondary antibodies (Molecular Probes). The slides were wet-mounted and counterstained utilizing Vectashield with DAPI (Vector Laboratories) for staining of the nucleus.
TUNEL Staining
Fluorescein conjugated staining was performed using the "in situ Cell Death Kit" (Roche diagnostics), according to manufacturer's instructions. BrdU Staining Tissue sections of 4 μm thickness were deparaffinized, rehydrated and washed in 1x PBS. Endogenous peroxidase activity was quenched with 3% hydrogen peroxide in methanol for 30 min and HIER was performed. The sections were washed and incubated in 1 N HCl for 10min on ice followed by 2N HCL for 30min at 37 o C and final incubation in borate buffer (0.1M) for 10min at room temperature. After washing the sections were incubated in donkey blocking serum (3%, Sigma) at room temperature for 60 min followed by exposure to primary antibody, sheep anti-BrdU (Abcam) at a dilution of 1:100, overnight at 4 o C. The sections were incubated in Alexa Fluor 488 donkey anti-sheep secondary antibody (Molecular Probes) for 30 min and wetmounted.
Microscopic examination
The fluorescent images were captured using an Olympus BX60 microscope fitted with a Zeiss Axiocam MRm camera, using Slidebook v.4.1 software (Intelligent Imaging Innovations, Inc., Denver CO). The brightfield images were captured using the same Olympus microscope fitted with an Olympus Q-Color 6 camera, using QImaging software v.6.0 (Qimaging Corp., Surrey, BC, Canada). All digital images were processed using Photoshop 6 (Adobe Inc., San Jose, CA).
in situ hybridization
Antisense DIG-labeled Lgr5 probes were synthesized from mouse cDNA (ATCC #17081141) (Barker et al., 2007) . The tissue sections were deparaffinized, rehydrated and incubated in 0.2M HCl to reduce background. Proteinase K digestion was carried out using 30μg/ml Proteinase K (Roche) for 13 min at room temperature followed by 7min at 37 o C. Postfixation, the sections were treated with acetic anhydride, rinsed and hybridized with the probe for 48 hours at 65 o C. The probes were detected using anti-DIG AP antibodies (1:2000) overnight at 4 o C, and BM Purple solution (Roche 11093274910 and 11442074001, respectively), overnight at room temperature.
